Why Read?
You and I both know that printing tissue from our own cells is the future of ortho.
It's a matter of when not if.
Luckily, the successful co-founder of Embody (who sold to ZB) is in the game.
Below you will discover the potential of Asante Bio's stem cell-derived cartilage implants in revolutionizing early osteoarthritis treatment, as this deep dive uncovers the innovative science, visionary leadership, funding trajectory, and market-disrupting edge of a startup poised to transform orthopedic care.
Overview of Asante Bio
Asante Bio is an early-stage biotechnology startup specializin...
